This comprehensive and authoritative reference covers all aspects of the group of disorders collectively known as the lymphoid neoplasms. The reader is taken through a description of its normal cellular origins and the molecular genetic abnormalities that can lead to this group of conditions, a section of the book that has been considerably strengt

Introduction to Neuropathology 3Ed remains an introductory text, but more clinical material has been introduced to make it relevant to neurologists and some psychiatrists, as well as pathologists. This involves the addition of small amounts of text throughout, plus neuroimages, including functional MRI, which is in colour. In addition, the text has

With the 13th edition, Wintrobe’s Clinical Hematology once again bridges the gap between the clinical practice of hematology and the basic foundations of science. Broken down into eight parts, this book provides readers with a comprehensive overview of: Laboratory Hematology, The Normal Hematologic System, Transfusion Medicine, Disorders of Red Cells, Hemostasis and Coagulation; Benign Disorders of Leukocytes, The Spleen and/or Immunoglobulins; Hematologic Malignancies, and Transplantation. Within these sections, there is a heavy focus on the morphological exam of the peripheral blood smear, bone marrow, lymph nodes, and other tissues. With the knowledge about gene therapy and immunotherapy expanding, new, up-to-date information about the process and application of these therapies is included. Likewise, the editors have completely revised material on stem cell transplantation in regards to both malignant and benign disorders, graft versus host disease, and the importance of long-term follow-up of transplantation survivors.

Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers. The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect.

Previous editions of this book have proved indispensable for trainee surgeons preparing for the MRCS and AFRCS examinations. This extensively revised new edition is presented in a compelling new style and in a larger format. Beginning with a 'route-map' showing 'how to use this book', the text offers concise accounts of the core topics in pathology required of surgeons in training. There is particular emphasis on tissue pathology but full account is taken of relevant aspects of microbiology, haematology, immunology and clinical chemistry. Tables of normal laboratory values are included. Each major disorder is examined from the point of view of Cause, Structure, and Behaviour. Genetics, molecular biology and imaging receive balanced attention as do transfusion, telepathology and audit. The use of computers is outlined and suggestions given on access to Internet sources for learning purposes. The needs of trainees in countries outside Europe have been considered carefully. Illustrations have been selected to provide a clear, pictorial account of complex points. The inclusion of biographies of surgical pioneers adds interest and enables candidates to put their knowledge into context. A special feature is a series of marginal 'signposts' in the form 'Now Read' that take candidates to interrelated topics quickly and easily. There is extensive cross-referencing and a comprehensive index.

Two leading oncologists, along with experts spanning several medical disciplines, shed light on the global pandemic of cancer, particularly the difference in diagnosis, treatment, and care between global communities. Despite advancing globalization and amazing breakthroughs in modern medicine, developing countries continue to struggle with the prevention and treatment of the most common killer in the world today—cancer. Logistical barriers, scarceness of resources, and economic hardships in these regions make the screening, detection, and care of this disease difficult at best. This book is the only one of its kind to review the pandemic of cancer from a global and epidemiological perspective. The work is presented in three sections, focusing on key issues in cancer management, treatment of specific types of the disease, and the difference in medical care between low-, medium-, and high-resource countries. Chapters address the history, incidence, and treatment across nations; presiding cultural attitudes which may delay or prevent treatment in many parts of the world; and the geopolitics of cancer care and funding. Patients and caregivers from all around the globe explain the daily challenges of living with the disease in their nation.

Biomedical research is the first step towards the creation of new medications and treatments that help to manage different types of health conditions and diseases. The prevention and cure of diseases would be practically impossible without such type of research. Although the drug discovery and development processes are far too costly, time-consuming, prone to failure, and have low success rate, today the term "translational research or medicine" seems to have become trendy, yet it is insufficient. The present book is a sincere attempt by dedicated researchers to convey the importance of translational biomedical research, medicine, and disease, primarily, basic and clinical difficulties in the translation of diagnostic measures, pharmaceutical advances, biomarkers, diagnostics, and therapeutics. This book is meant for researchers, scientists, healthcare professionals, industry, innovators, and students of biomedical sciences, as well as for those involved in the basic sciences, biochemistry, biotechnology, biophysics, and life sciences in general. The volume comprehensively covers: Emerging technologies for health care Various aspects of biomedical research toward understanding of pathophysiology of the diseases Advances in improvement in diagnostic procedures and therapeutic tools The fundamental role of biomedical research in the development of new medicinal products